Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...

Howard Lutnick, chairman and CEO of investment firms Cantor Fitzgerald and BGC Group, told the U.S. Senate Committee on ...

Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.

Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...

Cantor Fitzgerald raised the firm’s price target on Tesla (TSLA) to $425 from $365 and keeps a Neutral rating on the shares. Tesla’s adjusted ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...

Research analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for shares of Sanara MedTech in a research report issued on Thursday, January 23rd. Cantor Fitzgerald ...

Howard Lutnick, the wealthy Wall Street executive whom President Trump has tapped to lead the Department of Commerce, ...